Congress Materials – American Society for Clinical Pharmacology & Therapeutics (ASCPT 2025)
2025 American Society for Clinical Pharmacology & Therapeutics | May 28-31 | Washington, DC
This section includes selected Johnson & Johnson Innovative Medicine abstracts, posters, or oral presentations, which have been accepted for congress presentations in the last 2 years or less (as determined by any congress restrictions on length of time materials can be posted). Information about pipeline products or investigational uses of products does not imply FDA approval for these products or uses, nor does it establish the safety or efficacy of these products or uses. Johnson & Johnson does not recommend or suggest use of its medicines in a manner inconsistent with FDA-approved labeling. The content contained in this section is subject to congress copyright permissions.
ADME Profiling of Targeted Oral Peptide JNJ-77242113 (Icotrokinra)
Beverly Knight, Shannon Dallas, Saro Mardirosian, Jianyao Wang, Aline Laenen, Laurent Leclercq, Darren Moss, Karen DiLoreto, Seonghee Park, David Polidori, Carlo Sensenhauser, Anthony Ndifor, Yifan Shi, Shefali Patel, Anne Fourie, Raymond Patch, Chengzao Sun, Mario Monshouwer
This document will be available on May 28 2025
Pharmacokinetics Bridging of Icotrokinra (JNJ-77242113) Oral Solution and Tablet Formulations
Tristan Baguet, Brinda Tammara, Joyce Ojeda, Grace Liu, Julie Badamo, Beverly Knight, Cynthia DeKlotz, Teddy Kosoglou, An Vermeulen
This document will be available on May 28 2025
Copies of these presentations are for personal use only and may not be reproduced without written permission from the presentation author.